Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disulfiram hepatotoxicity: case report.

J L Black, J W Richardson

    The Journal of Clinical Psychiatry
    |February 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Disulfiram is a common alcoholism treatment with few side effects. A rare hepatotoxic reaction occurred, but the risks of continued drinking are greater than disulfiram risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Black Hole Spectroscopy and Tests of General Relativity with GW250114.

    Physical review letters·2026
    Same author

    GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

    Physical review letters·2025
    Same author

    Improving cosmological reach of a gravitational wave observatory using Deep Loop Shaping.

    Science (New York, N.Y.)·2025
    Same author

    Squeezing the quantum noise of a gravitational-wave detector below the standard quantum limit.

    Science (New York, N.Y.)·2024
    Same author

    Search for Subsolar-Mass Binaries in the First Half of Advanced LIGO's and Advanced Virgo's Third Observing Run.

    Physical review letters·2022
    Same author

    Point Absorber Limits to Future Gravitational-Wave Detectors.

    Physical review letters·2021
    Same journal

    Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

    The Journal of clinical psychiatry·2026
    Same journal

    Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

    The Journal of clinical psychiatry·2026
    Same journal

    Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

    The Journal of clinical psychiatry·2026
    Same journal

    Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

    The Journal of clinical psychiatry·2026
    Same journal

    The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

    The Journal of clinical psychiatry·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Hepatology
    • Addiction Medicine

    Background:

    • Disulfiram is a well-established medication used as an adjunct therapy for alcohol use disorder.
    • It functions by inhibiting aldehyde dehydrogenase, leading to an unpleasant physical reaction upon alcohol consumption.
    • The medication is generally well-tolerated with a low incidence of significant side effects.

    Observation:

    • A case report details an alcoholic patient experiencing a hepatotoxic reaction during disulfiram treatment.
    • Hepatotoxicity is a known, albeit uncommon, potential adverse effect of disulfiram therapy.
    • This specific instance highlights the importance of monitoring liver function in patients undergoing treatment.

    Findings:

    • The patient developed liver damage while taking disulfiram.

    Related Experiment Videos

  • Despite the observed hepatotoxicity, the overall risk-benefit profile favors disulfiram use in managing alcoholism.
  • The dangers associated with untreated alcoholism and continued alcohol consumption are significantly higher than the risks associated with disulfiram therapy.

    • Implications:

    • This case underscores the need for vigilance regarding potential disulfiram-induced liver injury.
    • It reinforces that the therapeutic benefits of disulfiram in preventing relapse outweigh the risks of rare adverse events.
    • Clinicians should carefully weigh the risks of continued alcohol abuse against the potential side effects of disulfiram when managing patients with alcohol use disorder.